Audrey G.
- Country
- France
- Department
- Hématologie et oncologie pédiatrique
Research Overview
- Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia
- AALL2131/EsPhALL2022, An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitor with Blinatumomab in Patients with Newly Diagnosed Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
Data & Insights
Has run more than one trial at 62 of 175 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating acute lymphoblastic leukemia in infants, with particular focus on patients under one year of age. Their research interest centers on developing innovative therapeutic approaches for this challenging pediatric condition.
- Infant Leukemia Treatment
- Early-onset ALL Management
- Pediatric Cancer Care
The investigator's work encompasses the study of KMT2A-rearranged leukemia, a specific genetic subtype that affects infant patients.
Hematologic Malignancies
Their expertise extends to the treatment of blood-based cancers, with specific emphasis on understanding and improving survival outcomes in pediatric hematologic conditions.
- Blood Cancer Therapeutics
- Leukemia Protocol Development
- Treatment Outcome Analysis
The investigator focuses on enhancing event-free survival rates through advanced therapeutic protocols.
Genetic Oncology
The investigator's work involves the study of genetic factors in pediatric leukemia, particularly focusing on specific genetic rearrangements that influence disease progression and treatment response.
- Genetic Markers in ALL
- Molecular Disease Classification
- Targeted Therapy Approaches
Their research includes analysis of molecular subtypes to optimize treatment strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.